Observational Study to Evaluate Safety of Cell-derived A/H1N1 Influenza HA Vaccine in Healthy Japanese Subjects.
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- 24 Oct 2011 Actual end date (November 2010) added as reported by ClinicalTrials.gov.
- 24 Oct 2011 Status changed from active, no longer recruiting to completedas reported by ClinicalTrials.gov.
- 20 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.